Objective To investigate the expression of the leukocyte differentiation antigen CD38 and multiple myeloma oncogene 1 ( MUM-1) in liver biopsy tissue of patients with autoimmune hepatitis ( AIH) , as well as their roles in the development and progression of AIH. Methods Liver biopsy tissue samples from 46 AIH patients who were admitted to Department of Pathology in Wuxi Fifth People's Hospital from January 2017 to December 2018 were selected as experimental group, and normal liver tissue samples from 30 patients with gallbladder carcinoma who underwent radical treatment were selected as control group. Immunohistochemistry was used to measure the expression of CD38 and MUM-1, and an analysis was performed with reference to patients' clinical and pathological features. The Wilcoxon rank-sum test was used for comparison of non-normally distributed continuous data between two groups, the chi-square test was used for comparison of categorical data between groups, and a Spearman correlation analysis was also performed. Results The experimental group had significantly higher expression of CD38 and MUM-1 than the control group ( Z =-7. 181 and-7. 484, both P < 0. 001) . The AIH patients with inflammatory activity grade ≥3 and fibrosis stage 4 had significant increases in the expression of CD38 and MUM-1, with significantly higher expression than those with inflammatory activity grade < 3 and fibrosis stage < 4 ( χ2= 10. 085, 15. 769, 14. 988, and26. 966, all P < 0. 05) . The expression of CD38 and MUM-1 was positively correlated with chronic inflammatory activity grade and fibrosis stage ( r = 0. 552, 0. 876, 0. 603, and 0. 934, all P < 0. 001) , and CD38 was also positively correlated with MUM-1 ( r = 0. 932, P <0. 001) . Conclusion CD38 and MUM-1 are involved in the inflammatory activity of AIH and the process of fibrosis formation. There is a synergistic effect between them, which affects the process of liver cirrhosis. Therefore, they may become potential targets for diagnosis and treatment in future.
[1] LONGHI MS, MA Y, MIELI-VERGANI G, et al. Aetiopathogenesis of autoimmune hepatitis[J]. J Autoimmun, 2010, 34 (1) :7-14.
|
[2] KLEIN U, CASOLA S, CATTORETTI G, et al. Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination[J]. Nat Immunol, 2006, 7 (7) :773-782.
|
[3] HENN EM, ZENIYA M, CZAJA AJ, et al. Simplified diagnostic criteria for autoimmune hepatitis[J]. Hepatology, 2008, 48 (1) , 169-176.
|
[4] DANIELS JA, TORBENSON M, ANDERS RA, et al. Immunostaining of plasma cells in primary biliary cirrhosis[J]. Am J Clin Pathol, 2009, 131 (2) :243-249.
|
[5] WANG W, SUN W, SU JR, Analysis on the significance of IgG4 level and related serological markers in patients with autoimmune liver disease[J]. J Clin Exp Med, 2018, 17 (19) :2072-2075. (in Chinese) 王炜, 孙伟, 苏建荣.自身免疫性肝病患者的IgG4水平及相关血清学指标分析[J].临床和实验医学杂志, 2018, 17 (19) :2072-2075.
|
[6] Chinese Society of Hepatology, Chinese Medical Association;Chinese Society of Gastroenterology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association. Consensus on the diagnosis and management of autoimmune hepatitis (2015) [J]. J Clin Hepatol, 2016, 32 (1) :9-22. (in Chinese) 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会.自身免疫性肝炎诊断和治疗共识 (2015) [J].临床肝胆病杂志, 2016, 32 (1) :9-22.
|
[7] ZHENG LP, ZHANG WJ. The expression and clinical application prospect of CD38[J]. Int J Immunol, 2006, 29 (4) :245-247. (in Chinese) 郑丽平, 张伟京. CD38分子的表达及临床应用前景[J].国际免疫学杂志, 2006, 29 (4) :245-247.
|
[8] HORENSTEIN AL, STOCKINGER H, IMHOF BA, et al. CD38binding to human myeloid cells is mediated by mouse and human CD31[J]. Biochem J, 1998, 330 (Pt3) :1129-1135.
|
[9] YUE LT, LIU WB, WANG Y, et al. CD38 expression in the peripheral blood and synovial tissues from patients with rheumatoid arthritis[J]. Current Immunology, 2014, 34 (2) :89-93. (in Chinese) 岳龙涛, 刘文波, 王瑶, 等. CD38在类风湿关节炎外周血与滑膜组织中的表达[J].现代免疫学, 2014, 34 (2) :89-93.
|
[10] PAN WP. The abnormal expression and effects of CD38 in rheumatoid arthritis[D]. Shandong University, 2017. (in Chinese) 潘文萍. CD38分子在类风湿关节炎的表达和作用机制研究[D].山东大学, 2017.
|
[11] MALLONE R, ORTOLAN E, PINACH S, et al. Anti-CD38 autoantibodies:Characterisation in new-onset type I diabetes and latent autoimmune diabetes of the adult (LADA) and comparison with other islet autoantibodies[J]. Diabetologia, 2002, 45 (12) :1667-1677.
|
[12] MARCHETTI P, ANTONELLI A, LUPI R, et al. Prolonged in vitro exposure to autoantibodies against CD38 impairs the function and survival of human pancreatic islets[J]. Diabetes, 2000, 51 (3) :s474-s477.
|
[13] LIU CJ, LIU HC, YIN GP. The expression of CD38 on the peripheral blood lymphocytes in patients with SLE[J]. China J Leprosy Skin Dis, 2001, 17 (3) :162-163. (in Chinese) 刘翠杰, 刘华昌, 尹格平.系统性红斑狼疮病人外周血淋巴细胞CD38的表达[J].中国麻风皮肤病杂志, 2001, 17 (3) :162-163.
|
[14] YOU HQ, GUO J, LI S, et al. Function of CD38 signal pathway in neuroimmuno regulation network[J]. Chin J Neuroimmunol Neurol, 2014, 21 (3) :192-195. (in Chinese) 游红琴, 郭建, 李沙, 等. CD38在中枢神经免疫调节相关信号链中的作用[J].中国神经免疫学和神经病学杂志, 2014, 21 (3) :192-195.
|
[15] QIN G, SHEN Y, HUA Y, et al. Expression and significance ofγδT cells in experimental autoimmune hepatitis[J]. Prog Microbiol Immunol, 2017, 45 (3) :7-13. (in Chinese) 秦刚, 沈毅, 化雨, 等.γδT细胞在实验性自身免疫性肝炎中的表达及意义[J].微生物学免疫学进展, 2017, 45 (3) :7-13.
|
[16] GUALCO G, WEISS LM, BACCHI CE. MUM1/IRF4:A review[J].Appl Immunohistochem Mol Morphol, 2010, 18 (4) :301-310.
|
[17] KLEIN U, CASOLA S, CATTORETTI G, et al. Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination[J]. Nat Immunol, 2006, 7 (7) :773-782.
|
[18] AHYI AN, CHANG HC, DENT AL, et al. IFN regullatory factor4 regulates the expression of a subset of Th2 cytokines[J]. J Immunol, 2009, 183 (3) :1598-1606.
|
[19] BEHFARJAM F, SANATI MH, NASSERI MS, et al. Role of Th1/Th2 cells and related cytokines in autoimmune hepatitis[J]. Turkish J Gastroenterol, 2017, 28 (2) :110-114.
|